{"entity":{"id":"rscm-jakarta","kind":"institution","name":"Dr. Cipto Mangunkusumo National Central General Hospital (RSCM)","aka":["RSCM","RSUPN dr. Cipto Mangunkusumo","Cipto Mangunkusumo Hospital"],"tldr":"A national referral hospital in Jakarta for care, teaching and research, which works with Universitas Indonesia. It collects cancer registry data for all five Jakarta municipalities and hosts academic cancer trials.","summary":"Cipto Mangunkusumo (RSUP Nasional Dr. Cipto Mangunkusumo) is a national central general hospital in central Jakarta; its own website describes it as a national referral hospital for care, education and research. The national cancer plan names it, with Universitas Indonesia, as a site of specialist medical physics training. In the national cancer plan it is one of the fourteen hospitals that collect data for the Indonesian cancer registry, covering the five municipalities of Jakarta, and was a regional coordinating hospital for central Jakarta in the 2008 to 2010 registry pilot.\n\nThe plan cites a study of patients receiving radiotherapy at the national referral hospital, published through Universitas Indonesia in 2024, in which 79 per cent reported financial toxicity in meeting daily household needs despite JKN cover (38 per cent mild, 39 per cent moderate, 2 per cent severe). On ClinicalTrials.gov it is the site of a phase 2 trial of simvastatin in breast cancer sponsored by Universitas Indonesia (NCT05550415).","asOf":"2026-11-04","links":[{"label":"Kementerian Kesehatan: Rencana Kanker Nasional 2024-2034, updated edition (PDF), pages 8, 34 and 80 to 82","url":"https://repository.badankebijakan.kemkes.go.id/id/eprint/5958/1/Rencana%20Kanker%20Nasional%202024-2034_V71.pdf"},{"label":"RSCM: Tentang RSCM (hospital website)","url":"https://www.rscm.co.id/"},{"label":"ClinicalTrials.gov NCT05550415","url":"https://clinicaltrials.gov/study/NCT05550415"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["indonesia-cancer-registry","kemenkes-indonesia"],"pathways":[],"terms":[],"trials":["nct05550415"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Jakarta","country":"ID","lat":-6.1973,"lng":106.8467,"institutionType":"hospital","website":"https://www.rscm.co.id","university":"Universitas Indonesia","programs":["Indonesian cancer registry data collection for Jakarta","Radiotherapy","Medical physics specialist training with Universitas Indonesia"]},"route":"/institutions/rscm-jakarta/","neighbours":{"institution":[{"id":"bpjs-kesehatan","kind":"institution","name":"BPJS Kesehatan (Indonesia's national health insurance agency)","route":"/institutions/bpjs-kesehatan/"},{"id":"indonesia-cancer-registry","kind":"institution","name":"Indonesian National Cancer Registry (Registrasi Kanker Nasional)","route":"/institutions/indonesia-cancer-registry/"},{"id":"kemenkes-indonesia","kind":"institution","name":"Ministry of Health of Indonesia (Kementerian Kesehatan)","route":"/institutions/kemenkes-indonesia/"}],"trial":[{"id":"nct05550415","kind":"trial","name":"The Role of Simvastatin in The Epithelial-Mesenchymal Transition Process of Breast Cancer","route":"/trials/nct05550415/"}]}}